The emergence of resistant pneumococcal meningitis--implications for empiric therapy

P McMaster1, P McIntyre, R Gilmour

  • 1Department of Immunology and Infectious Diseases, The Children's Hospital at Westmead, PO Box 3515, Parramatta, NSW 2124, Australia.

Abstract

Insights

Delayed lumbar puncture in pneumococcal meningitis increases disease severity. Empiric vancomycin is most justified for delayed lumbar punctures, but can be withheld if Gram-positive diplococci are not seen on early lumbar puncture.

Area of Science:

  • Pediatric Infectious Diseases
  • Bacterial Meningitis Pathogenesis
  • Antibiotic Resistance Epidemiology

Background:

  • Penicillin and cephalosporin resistance in pneumococcal meningitis prompted vancomycin recommendations.
  • Limited data exist to evaluate the efficacy of this empiric vancomycin policy.

Purpose of the Study:

  • To assess management and clinical outcomes of pneumococcal meningitis in children.
  • To correlate outcomes with antibiotic therapy in an area of increasing antibiotic resistance.

Main Methods:

  • Retrospective review of 104 pediatric pneumococcal meningitis cases in Sydney, Australia (1994-1999).
  • Analysis of lumbar puncture timing, antibiotic use, and disease severity.
  • Evaluation of penicillin resistance trends.

Main Results:

  • Penicillin resistance increased from 0% to 20% during the study period.
  • Early lumbar puncture (prior to antibiotics) occurred in only 55% of cases.
  • Delayed or no lumbar puncture was associated with significantly increased severe disease (42%-62%) compared to early lumbar puncture (28%).
  • Empiric vancomycin use did not correlate with patient outcomes.

Conclusions:

  • Lumbar puncture is frequently delayed in pediatric pneumococcal meningitis.
  • Empiric vancomycin is most indicated when lumbar puncture is deferred due to increased disease severity.
  • Vancomycin may be withheld if Gram-positive diplococci are absent on early lumbar puncture results.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...